EDWARD WELSH MARCH 31 2010 Dialysis Adequacy (?).

Slides:



Advertisements
Similar presentations
Separation Technology in Dialysis
Advertisements

MNT Approaches to Acute and Chronic Kidney Disease
Pediatric CRRT: Terminology and Physiology
Hemodiafiltration and Hemofiltration
Hemodialysis Adequacy
Kidney Physiology Kidney Functions: activate vitamin D (renal 1-alpha hydroxylase)activate vitamin D (renal 1-alpha hydroxylase) produces erythropoietin.
How best to control salt overload in hypertension? - Dietetic? - Aligning dialysate sodium with patient's serum sodium -Prohibition of sodium profiling.
Sodium flux during dialysis
MANAGEMENT OF CONTINUOUS HEMODIALYSIS
Clinical case presentation
NON-TRADITIONAL RENAL REPLACEMENT THERAPY Hafez Bazaraa.
West Midlands Guidelines for managing CKD Mineral and Bone Disorders in Haemodialysis Patients
Measurement and preservation of residual renal function (RRF) in haemodialysis patients Elizabeth Lindley and David Keane Leeds Teaching Hospitals NHS.
Kidney and renal dialysis
Continuous Renal Replacement Therapy. Why continuous Therapies? Continuous therapies closely mimic the GFR of native kidneys Large amounts of fluid.
Strategies for Improving Adequacy Decreasing the Risk of Premature Death Educate Your Dialysis Team Review Proper Procedure for Drawing Lab Samples - Lab.
HEMODIALYSIS ADEQUACY HEMODIALYSIS ADEQUACY Laurie Vinci RN, BSN, CNN Laurie Vinci RN, BSN, CNN September 17, 2011 September 17, 2011.
Hemodialysis adequacy & Outcome: from NCDS to HEMO & MPO
Kidney Function Tests Contents: Kidney functions Functional units Renal diseases Routine kidney function tests Serum creatinine Creatinine clearance.
Elimination of Phosphate in HD and PD Reference: Kuhlmann MK. Phosphate elimination in modalities of hemodialysis and peritoneal dialysis. Blood Purif.
Pharmacotherapy in the Elderly Judy Wong
PRINCIPLES OF DIALYSIS DR SAAD ALSHOHAIB ASSOCIATE PROFESSOR IN MEDICINE AND NEPHROLOGY KAUH.
Kidney Function Tests Rana Hasanato, MD, KSFCB
Kidney Function Tests Contents: Functional units Kidney functions Renal diseases Routine kidney function tests Serum creatinine Creatinine clearance.
Pediatric CRRT: The Prescription
Md.Kausher ahmed Electrical department. Biomedical engineering Code:6875.
Urinary System. Secreted Substances Secreted Substances Hydroxybenzoates Hydroxybenzoates Hippurates Hippurates Neurotransmitters (dopamine) Neurotransmitters.
Diseases of the Renal System KNH 413. CKD - Renal Replacement Therapy Hemodialysis (HD) or Peritoneal Dialysis (PD) Type based on underlying kidney disease.
Dose Adjustment in Renal and Hepatic Disease
Biotransformation and metabolism
Kidney Function Tests.
Regulate the composition of your blood
APPLICATION OF INDIVIDUALIZED BAYESIAN UREA KINETIC MODELING TO PEDIATRIC HEMODIALYSIS Olivera Marsenic, Athena Zuppa, Jeffrey S. Barrett, Marc Pfister.
© ANZDATA Registry Method and Location of Dialysis (31%) 634 (12%) 1396 (26%) 1523 (28%) Number of Patients Australia 30-Sep-98 METHA.BRIS98.
Common Prescription Errors in Pediatric CRRT: a “Top 10 List” Jordan M. Symons, MD University of Washington School of Medicine Seattle Children’s Hospital.
“Adequacy in PD prescription What, How, When?
Common Terminology Used and Physiology in CRRT Jordan M. Symons, MD University of Washington School of Medicine Seattle Children’s Hospital Seattle, WA.
Chronic renal failure and common accompanying diseases Hradec Králové, November 2007 © by Adrian Franke.
Acute Renal Failure Doç. Dr. Mehmet Cansev. Acute Renal Failure Acute renal failure (ARF) is the rapid breakdown of renal (kidney) function that occurs.
Progression of Chronic Kidney Disease
Dosing of Anti-Fungal agents on CRRT Timothy E. Bunchman Professor and Director Pediatric Nephrology & Transplantation Children’s Hospital of Richmond.
Hemodialysis Adequacy and Monitoring Stuart L. Goldstein, MD Professor of Pediatrics University of Cincinnati College of Medicine Director, Center for.
Anna Drinkwater UHNS.  Dialysis at least 3 x weekly  Vascular access ◦ 80% HDx patients should dialyse via arteriovenous fistula  Serum PO4
Foundation Knowledge and Skills
The Kidney & Dialysis Diffusion, osmosis, & active transport in the body.
Hemodiafiltration: Clinical Evidence of Higher Benefit Reference: Blankestijn PJ, LedeboI, Canaud B. Hemodiafiltration: Clinical evidence and remaining.
KT AS A QUALITY INDICATOR OF HAEMODIALYSIS ADEQUACY: COMPARISON OF KT/V, KT ACCORDING TO THE GENDER AND BODY SURFACE AREA The dialysis dose monitored with.
Hemodialysis.
신장내과 R4 김효식 /Prof. 전진석 혈액투석의 시작. Dialysis start Patients with eGFR >15 mL/min/1.73 m 2 Generally do not initiate chronic dialysis for such patients, ev.
BASIC PRINCIPLES OF DIALYSIS
HAEMODIALYSIS ADEQUACY
RENAL REPLACEMENT THERAPIES
The HEMO Study Hemodialysis (HEMO) Study Reference
Spotlight on general principles of hemodialysis
HEMODIALYSIS ADEQUACY
Hemodialysis Lecture (2).
6/18/2018 Intensive Care; Acute Renal Failure 1 Continuous Renal Replacement Therapy (CRRT) Maureen Walter,Raquel Lomeli Anika Stevenson,Nellie Preble.
Acute and Chronic Renal Failure
Renal Disease Filtration, glomeruli generate removal ultrafiltrate of the plasma based on size and charge of molecules End products include urea, creatinine,
Pharmacokinetics & Drug Dosing
Downloadable computer models for renal replacement therapy
Nephrology Skills Laboratory
Andrew Durward St Thomas NHS Foundation Trust Orlando 2017 CRRT IN AKI.
Clinical Practice Guidelines for Hemodialysis Adequacy, Update 2006
Dialyzer Math.
Renal replacement therapy
Joachim Böhler, M.D., Johannes Donauer, Frieder Keller 
Volume 80, Issue 10, Pages (November 2011)
Confounding factors in the assessment of delivered hemodialysis dose
Stock and Flow of Haemodialysis Patients Australia
Presentation transcript:

EDWARD WELSH MARCH Dialysis Adequacy (?)

Disclaimer

Adequate Equal to a requirement Barely satisfactory Acceptable Would you be happy with “adequate” therapy ?

Outline Basics of renal function History and Trials Formulae Problems

Kidney Function Maintain a steady state environment Continuous function and adjustment of metabolic parameters Filtration Secretion Metabolic Synthetic

Uremic Toxins Many known, many more unknown Small water soluble – urea Larger water soluble –guanidines Phosphates Protein bound compounds- cresols, drugs Middle molecules (MW>500 D)- greater than 20 compounds….AGE’s, B2M, PTH

Hemodialysis Replaces filtration Diffusive and convective losses Intermittent and short duration – 12 hours vs 168

Cont’ Removes volume, electrolytes, water soluble wastes and ( slowly) middle molecules and P04 No metabolism No secretion No synthetic function No removal of protein bound wastes

Urea Kinetic Modeling TAC, AUC Kt/V URR PRU eKt/V Single pool Kt/V Double pool V

Area under the Curve

History ? Quantity dialysis correlated with outcome Initially used nerve conduction, bleeding times, EEG - all poorly standardized Various toxins proposed/measured – middle molecules (B12 used as marker) Urea shown not to have toxic effects

First Study National Cooperative Dialysis Study (NCDS) published patients from 8 US centers 4 groups - 4 ½ hours and high TAC (36) - 4 ½ hours and low TAC (18) - 3 ½ hours and high TAC - 3 ½ hours and low TAC 3 runs per week, no real diet

Outcome Study stopped early – analysis revealed higher mortality in high TAC group Seemed to validate urea as useful marker Reanalysis data in 1985 – Gotch – led to UKM and Kt/V Kt/V of 0.9 considered minimum High TAC, 3 ½ hour group received Kt/V of 0.4 !

Oops Fixation on urea alone led to “high efficiency” dialysis with short runs mid 80’s to early 90’s in the US Poor outcomes Rest of world better outcomes – longer times Tassin - 3 runs per week, 8 hours per run

HEMO Trial 2002 ? Optimal dialysis dose 1846 patients Standard vs high dialysis dose and low vs high flux dialyzers Standard dose group - Kt/V = 1.25 High dose group - Kt/V = 1.65

Hemo outcomes

Outcome 17% mortality rate per year 40% due to cardiac events NO difference between any groups !

Risk of Death vs URR or Alb

URR

Albumin

Kt/V K= dialyzer clearance t = time on dialysis V = volume of patient body water

? Calculate KT/V Need pre/post urea Existing patient data Treatment info All done same day Need computer program

Urea Reduction Ratio (URR) (Pre Urea – Post Urea ) /Pre Urea A single snapshot, easy to calculate PRU = URR x 100%

Prescribed vs Actual Prescribed - computerized estimation Actual – real run….. access that day, blood flow rates, treatment time

Timing When to measure post urea ? Too soon – post too low Single pool Recirculation Compartment dysequilibrium

Timing of Post Urea

Dialyzers Urea removed in relation to dialyzer surface area Larger surface area = greater removal urea Appropriate heparin to prevent clotting No reuse

Other factors Actual time on run Access type ? Recirculation Blood flow and dialysate flow rates – real vs entered Episodes hypotension…..

KDOQI guidelines 2006 Three runs a week Minimum run time 3 hours Kt?/V - target 1.4 with min 1.2 URR -target 70% with min 65% Kt/V is standard of practice

Netherlands Cooperative Study Residual renal function (RRF) Low Kt/V associated with mortality in anuric pts Need to consider both dialysis and renal Kt/V Excess interdialytic weight gain correlated with increase in mortality independent of Kt/V !

Conclusions Urea kinetics useful, but is only one measure of adequacy Other measures - Quality of life - Volume and BP control - Ca x Po4 - B2M….. LOOK at the patient !

Questions ?